Sequenom Sues Aria, Natera for Patent Infringement | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom has sued both Aria Diagnostics and Natera, accusing the companies of infringing a Sequenom patent with their respective noninvasive trisomy 21 and paternity tests.

In its complaint against Aria, filed with the US District Court for the Southern District of California, Sequenom alleges that Aria's prenatal trisomy test infringes its patent, US Patent No. 6,258,540, and that Aria's infringement has been "intentional, deliberate, and willful."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.